Stock Plans - Stock Option Plans (Details)	12 Months Ended
	Oct. 31, 2023 USD ($) $ / shares shares
Number of Shares
Vested and expected to vest at end of period (in shares) | shares	1,059,841
Vested and exercisable at end of period (in shares) | shares	729,591
Weighted- Average Exercise Price Per Share
Vested and expected to vest at end of period (in dollars per share) | $ / shares	$ 276.11
Vested and exercisable at end of period (in dollars per share) | $ / shares	$ 248.34
Share-based Compensation Arrangement by Share-based Payment Award, Options, Additional Disclosures [Abstract]
Vested and expected to vest at end of period, Weighted-Average Remaining Contractual Term (in years)	5 years 3 months 25 days
Vested and exercisable at end of period, Weighted-Average Remaining Contractual Term (in years)	4 years 4 months 17 days
Vested and expected to vest at end of period, Aggregate Intrinsic Value | $	$ 53,475,275
Vested and exercisable at end of period, Aggregate Intrinsic Value | $	$ 50,797,891
Stock Options
Number of Shares
Outstanding, beginning balance (in shares) | shares	1,063,843
Granted (in shares) | shares	86,241
Exercised (in shares) | shares	(71,808)
Forfeited or expired (in shares) | shares	(720)
Outstanding, ending balance (in shares) | shares	1,077,556
Weighted- Average Exercise Price Per Share
Outstanding, beginning balance (in dollars per share) | $ / shares	$ 264.85
Granted (in dollars per share) | $ / shares	329.83
Exercised (in dollars per share) | $ / shares	155.45
Forfeited or expired (in dollars per share) | $ / shares	337.72
Outstanding, ending balance (in dollars per share) | $ / shares	$ 277.29
Share-based Compensation Arrangement by Share-based Payment Award, Options, Additional Disclosures [Abstract]
Outstanding, ending balance, Weighted Average Remaining Contractual Term (in years)	5 years 4 months 9 days
Outstanding, ending balance, Aggregate Intrinsic Value | $	$ 53,510,367